Department of Cardiac, Thoracic and Vascular Surgery, Odense University Hospital, Odense, Denmark.
Department of Clinical Biochemistry and Pharmacology, University Hospital Odense, Odense, Denmark.
Eur J Vasc Endovasc Surg. 2021 Aug;62(2):267-274. doi: 10.1016/j.ejvs.2021.03.016. Epub 2021 May 2.
Inactivation of matrix Gla protein (MGP), using vitamin K antagonists or vitamin K deficiency results in increased vascular calcification, which has been associated with increased risk of symptomatic or ruptured abdominal aortic aneurysm (AAA). Insufficient activation of MGP leads to increased levels of undercarboxylated forms of MGP, measured as a dephosphorylated, undercarboxylated MGP (dp-ucMGP) in plasma. This study aimed to investigate whether the level of inactivated MGP influenced the risk of having an AAA, the risk of AAA progression, and overall mortality.
This combined case control and cohort study was based on data from the randomised, clinically controlled Viborg Vascular (VIVA) screening trial. Cases (n = 487) with an AAA and controls (n = 189) with neither peripheral artery disease nor AAA, had their plasma quantified for dp-ucMGP. Plasma levels were compared with the presence of an AAA, AAA growth rate, need for repair, and overall mortality. dp-ucMGP was divided into tertiles in regression analyses.
The plasma levels of dp-ucMGP were higher for AAA cases compared with controls (median of 517 pmol/L vs. 495 pmol/L, p = .036). Adjusted analyses regarding dp-ucMGP being predictive of AAA, AAA growth rate, and need for repair all failed to show correlation. Overall mortality for AAA cases exhibited a significant association for the third tertile of dp-ucMGP with a hazard ratio of 2.55 (95% CI 1.29 - 5.05) compared with the first tertile. Overall mortality for controls was not correlated with dp-ucMGP plasma levels.
dp-ucMGP did not correlate with the risk of having an AAA, AAA growth rate, or risk of surgery. For people with an AAA, dp-ucMGP was correlated with an increased mortality risk for the highest tertile of dp-ucMGP. This could suggest a role for prophylactic measures with vitamin K supplements to people at risk of AAA.
使用维生素 K 拮抗剂或维生素 K 缺乏症使基质 Gla 蛋白(MGP)失活会导致血管钙化增加,这与症状性或破裂性腹主动脉瘤(AAA)的风险增加有关。MGP 激活不足会导致未羧化形式的 MGP 水平升高,在血浆中表现为去磷酸化、未羧化的 MGP(dp-ucMGP)。本研究旨在探讨失活的 MGP 水平是否会影响 AAA 的发病风险、AAA 的进展风险和总死亡率。
本病例对照和队列研究基于随机、临床对照的 Viborg 血管(VIVA)筛查试验的数据。AAA 患者(n=487)和无外周动脉疾病或 AAA 的对照组(n=189)的血浆定量检测 dp-ucMGP。将血浆水平与 AAA 的存在、AAA 的增长率、修复的需要以及总死亡率进行比较。在回归分析中,dp-ucMGP 分为三分位。
与对照组相比,AAA 患者的 dp-ucMGP 血浆水平更高(中位数分别为 517 pmol/L 和 495 pmol/L,p=0.036)。关于 dp-ucMGP 预测 AAA、AAA 增长率和修复需要的调整分析均未显示相关性。AAA 患者的总死亡率与 dp-ucMGP 第三分位与第一分位相比,风险比为 2.55(95%CI 1.29-5.05),具有显著相关性。对照组的总死亡率与 dp-ucMGP 血浆水平无关。
dp-ucMGP 与 AAA 的发病风险、AAA 增长率或手术风险无关。对于患有 AAA 的人,dp-ucMGP 与 dp-ucMGP 最高三分位的死亡率增加相关。这可能表明对于有 AAA 风险的人,预防性使用维生素 K 补充剂可能具有作用。